TP53 and neoplasm: Complex karyotype sarcomas lack well‐understood genomic driver alterations and commonly harbor copy number alterations and loss of tumor suppressor genes such as TP53, RB1, NF1, and CDKN2A, which are challenging targets (Chen et al, 2020).